PRMT7 and hepatocellular carcinoma: HNF4α preferentially binds to this enhancer region with the risk allele G to activate PRMT7 transcription, and elevated PRMT7 promotes malignant phenotypes of HCC through inhibition of the p53 signaling cascade (25).